Ann & Robert H Lurie Childjren's Hospital of Chicago
Chicago, Illinois, 60611, United States
NCT Number: NCT05083156
The investigators seek to assess the efficacy of removing cow's milk from an EoE patient's diet. This will be determined by esophageal inflammation and clinical and histological response to the milk elimination treatment.
This study is active but is not currently recruiting participants.
1 year–18 year
All sexes
Observational
Chicago, Illinois, 60611, United States
The dietary approach is based on the hypothesis that food antigen(s) trigger eosinophilic inflammation and clinical and histological remission can be induced by identifying and excluding the causative food antigen(s). It is believed that eliminating causative food antigen(s) target the cause and thus induces long term remission.
This process is difficult as it requires multiple, invasive endoscopies and introduces the possibility of iatrogenic effects such as nutrient deficiency due to simultaneous multiple food eliminations. In addition, patient compliance may be compromised, both intentionally and unintentionally as many families report the elimination process to be both confusing and frustrating.
This prospective study eliminating only cow's milk proteins, which are a common cause of esophageal inflammation in patients with eosinophilic esophagitis, will assess the histological response in a cohort of children receiving care at Lurie Children's.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Observation Cohort will be observed for treatment response to elimination of cow's milk
Time frame: 1 year
Participants who have eliminated cow's milk will be clinically assessed to determine if histological remission, measured by Eos/hpf, was induced under this diet for children with EOE
Time frame: 1 year
Participant ages will be used in statistical analysis with eosinophil counts to determine if age is a predictor of response to treatment
Ann & Robert H Lurie Children's Hospital of Chicago
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05583227
Digestive System Diseases, Eosinophilia
Phoenix, Arizona, United States
View Trial DetailsNCT06851559
Digestive System Diseases, Eosinophilia
Little Rock, Arkansas, United States
View Trial DetailsNCT05176249
Digestive System Diseases, Eosinophilia
Chicago, Illinois, United States
View Trial DetailsNCT03822325
Digestive System Diseases, Eosinophilia
Chicago, Illinois, United States
View Trial Details